Special Investigation in Patients With Rheumatoid Arthritis (Combo Study : Adalimumab With High Dose MTX)
Phase of Trial: Phase IV
Latest Information Update: 17 May 2018
At a glance
- Drugs Adalimumab (Primary) ; Methotrexate
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
- Acronyms Combo; HAWK
- Sponsors Abbott Japan; AbbVie
- 04 May 2018 Status changed from active, no longer recruiting to completed.
- 30 Jan 2018 Planned End Date changed from 25 Dec 2017 to 16 Apr 2018.
- 30 Jan 2018 Planned primary completion date changed from 25 Dec 2017 to 16 Apr 2018.